Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02520154 |
| Title | Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | M.D. Anderson Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| MD Anderson in Katy | Houston | Texas | 77094 | United States | Details | |
| MD Anderson League City | Nassau Bay | Texas | 77058 | United States | Details | |
| MD Anderson in Sugar Land | Sugar Land | Texas | 77478 | United States | Details | |
| MD Anderson in The Woodlands | The Woodlands | Texas | 77384 | United States | Details |